Dr. Greg Vigna Therapeutic cooling reduces death and severe disability in neonates with HIE, but many still face cognitive and motor impair ...

Neuren Pharmaceuticals (ASX:NEU) has announced it will develop its drug candidate NNZ-2591 to treat hypoxic-ischemic ...

Neuren Pharmaceuticals has announced it will develop a new drug to treat a type of life-threatening brain injury in infants, ...

Let's see how the market has responded to these announcements. The post 2 ASX 200 biotech stocks announcing big news today ...

The Health Service Executive has said that work is continuing on a review of maternity services at Portiuncula University ...

Whole-body hypothermia within hours of birth failed to improve outcomes in preterm infants less than 36 weeks' gestational age with hypoxic-ischemic encephalopathy, a randomized clinical trial found.

Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy (HIE -- a type of brain damage caused by oxygen loss -- offers no ...

It would be easy to say that all infants who had any degree of hypoxia at birth would qualify ... 16 mmol/L and evidence of moderate or severe encephalopathy (Sarnet score) and aEEG recording ...

Lowering the body temperature of preterm infants (born at 33 to 35 weeks of pregnancy) with hypoxic ischemic encephalopathy (HIE)-a type of brain damage caused by oxygen loss-offers no benefits ...

Management of neurologic issues surrounds the identification and treatment of cerebral edema and hypoxic injury ... L and evidence of moderate or severe encephalopathy (Sarnet score) and aEEG ...